Ciltacabtagene autoleucel (cilta-cel) vs standard of care (SOC) in patients (pts) with relapsed/refractory multiple myeloma (MM): CARTITUDE-4 survival subgroup analyses.


Por: Sidana, S, Martinez-Lopez, J, Khan, AM, Oriol, A, Spencer, A, Dhakal, B, Cohen, YC, Touzeau, C, Dytfeld, D, Einsele, H, San-Miguel, J, Manier, S, Chen, Y, Li, K, Benachour, N, Lonardi, C, Ghosh, A, Patel, N, Florendo, E and Harrison, SJ

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Stanford Univ, Sch Med, Stanford, CA USA
Univ Complutense Madrid, Hosp Octubre 12, MIC, CNIO, Madrid, Spain
Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
Inst Catala Oncol, Barcelona, Spain
Hosp Germans Trias i Pujol, Inst Josep Carreras, Barcelona, Spain
Monash Univ, Alfred Hlth, Melbourne, Vic, Australia
Med Coll Wisconsin, Milwaukee, WI USA
Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel
Ctr Hosp Univ CHU Hotel Dieu, Serv Hematol, Nantes, France
Poznan Univ Med Sci, Poznan, Poland
Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
Univ Navarra, CIMA, IDISNA, Canc Ctr Clin, Pamplona, Spain
Univ Lille, CHU Lille, Lille, France
Johnson &Johnson, Shanghai, Peoples R China
Johnson & Johnson, Spring House, PA USA
Johnson & Johnson, Beerse, Belgium
Johnson & Johnson, Buenos Aires, Argentina
Johnson & Johnson, Raritan, NJ USA
Legend Biotech USA Inc, Somerset, NJ USA
Peter MacCallum Canc Ctr, Melbourne, Australia
Royal Melbourne Hosp, Melbourne, Australia
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas:
WOS Id: 001690254900035
imagen Bronze

MÉTRICAS